Axsome Therapeutics (AXSM) Assets Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.60% |
| Dec 31, 2025 | 21.34% |
| Sep 30, 2025 | 19.20% |
| Jun 30, 2025 | 16.70% |
| Mar 31, 2025 | 9.33% |
| Dec 31, 2024 | -3.36% |
| Sep 30, 2024 | -6.56% |
| Jun 30, 2024 | -10.37% |
| Mar 31, 2024 | 40.23% |
| Dec 31, 2023 | 77.46% |
| Sep 30, 2023 | 77.27% |
| Jun 30, 2023 | 238.75% |
| Mar 31, 2023 | 339.45% |
| Dec 31, 2022 | 277.60% |
| Sep 30, 2022 | 190.71% |
| Jun 30, 2022 | 26.03% |
| Mar 31, 2022 | -46.94% |
| Dec 31, 2021 | -52.84% |
| Sep 30, 2021 | -42.74% |
| Jun 30, 2021 | -24.99% |
| Mar 31, 2021 | -15.62% |
| Dec 31, 2020 | -15.60% |
| Sep 30, 2020 | 358.21% |
| Jun 30, 2020 | 248.66% |
| Mar 31, 2020 | 350.56% |
| Dec 31, 2019 | 1,334.07% |
| Sep 30, 2019 | 175.58% |
| Jun 30, 2019 | 152.14% |
| Mar 31, 2019 | 57.13% |
| Dec 31, 2018 | -56.75% |
| Sep 30, 2018 | -50.56% |
| Jun 30, 2018 | -44.36% |
| Mar 31, 2018 | -39.80% |
| Dec 31, 2017 | -6.95% |
| Sep 30, 2017 | -6.59% |
| Jun 30, 2017 | -2.41% |
| Mar 31, 2017 | 2.80% |
| Dec 31, 2016 | -22.14% |